MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.biopha.2021.112092

Медицинская библиотека · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021

Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease.

Mu Jian-Kang, Zi Lei, Li Yan-Qin, Yu Li-Ping, Cui Zheng-Guo, Shi Ting-Ting, Zhang Fan, Gu Wen, Hao Jun-Jie, Yu Jie, Yang Xing-Xin

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common global chronic liver disease. Jiuzhuan Huangjing Pills (JHP) have been used for the treatment of human disease for over a thousand years, but their efficacy and underlying mechanism(s) of action against MAFLD are unknown. We investigated the alleviating effects of JHP on high-fat diet (HFD)-induced MAFLD.

METHODS

In vitro and in vivo methods were used to evaluate the effects of JHP on MAFLD. L02 adipocyte models were induced by fat emulsion and adipocytes were treated with JHP for 24 h. MAFLD rat models were induced by HFD-feeding and were intragastrically administered JHP for 12 weeks. Changes in fat accumulation, L02 cell damage, body weight, food intake, histological parameters, organ indexes, biochemical parameters, and mitochondrial indicators including ultrastructure, oxidative stress, energy metabolism, and fatty acid metabolism were investigated.

RESULTS

JHP attenuated the increase in levels of total cholesterol, triglyceride, low density lipoprotein cholesterol, alanine transaminase, and aspartate transaminase levels, and significantly increased high density lipoprotein cholesterol. JHP up-regulated levels of glutathione (GSH) and superoxide dismutase (SOD), and down-regulated malondialdehyde (MDA). JHP afforded protection to the mitochondrial ultrastructure, and inhibited the HFD-induced increase in MDA and the reduction of SOD, GSH, ATP synthase, and complex I and II, in liver mitochondria. JHP regulated the expression of β-oxidation genes, including acyl-CoA dehydrogenase, cyl-CoA dehydrogenase long chain, carnitine palmitoyltransferase 1A, carnitine palmitoyltransferase 1B, peroxisomal proliferator-activated receptor-gamma coactivator-1α and peroxide proliferator activated receptor α.

CONCLUSION

JHP alleviates HFD-induced MAFLD through the protection of mitochondrial function.

Для цитирования: Mu Jian-Kang, Zi Lei, Li Yan-Qin, Yu Li-Ping, Cui Zheng-Guo, Shi Ting-Ting, Zhang Fan, Gu Wen, Hao Jun-Jie, Yu Jie, Yang Xing-Xin. Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021. DOI: 10.1016/j.biopha.2021.112092.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.